United States Bio-Artificial Systems Market Report 2016

October 2016 | 117 pages | ID: U14EA6B732CEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Bio-Artificial Systems

Revenue, means the sales value of Bio-Artificial Systems

This report studies sales (consumption) of Bio-Artificial Systems in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Xenios AG (Germany)
• Abbott Diabetes Care, Inc. (USA)
• Vital Therapies, Inc. (USA)
• Baxter International, Inc. (USA)
• Asahi Kasei Medical Co., Ltd. (Japan)
• Medtronic, Inc. (USA)
• HeartWare International, Inc. (USA)
• Fresenius Medical Care AG & Co. KGaA (Germany)
• Thoratec Corp. (USA)
• Toray Medical Co., Ltd. (Japan)
• Nikkiso Co., Ltd. (Japan)
• Nipro Corporation (Japan)
• SynCardia Systems, Inc. (USA)
• Terumo Heart, Inc. (USA)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Capillary Hollow Fiber Systems
• Direct Perfusion Systems
• Entrapment Based Systems
• Major BAL Devices
• Extracorporeal Liver Assist Device (ELAD)
• Hybrid Artificial Liver Support System

Split by applications, this report focuses on sales, market share and growth rate of Bio-Artificial Systems in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Bio-Artificial Systems Market Report 2016

1 BIO-ARTIFICIAL SYSTEMS OVERVIEW

1.1 Product Overview and Scope of Bio-Artificial Systems
1.2 Classification of Bio-Artificial Systems
  1.2.1 Capillary Hollow Fiber Systems
  1.2.2 Direct Perfusion Systems
  1.2.3 Entrapment Based Systems
  1.2.4 Major BAL Devices
  1.2.5 Extracorporeal Liver Assist Device (ELAD)
  1.2.6 Hybrid Artificial Liver Support System
1.3 Application of Bio-Artificial Systems
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Bio-Artificial Systems (2011-2021)
  1.4.1 United States Bio-Artificial Systems Sales and Growth Rate (2011-2021)
  1.4.2 United States Bio-Artificial Systems Revenue and Growth Rate (2011-2021)

2 UNITED STATES BIO-ARTIFICIAL SYSTEMS COMPETITION BY MANUFACTURERS

2.1 United States Bio-Artificial Systems Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Bio-Artificial Systems Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Bio-Artificial Systems Average Price by Manufactures (2015 and 2016)
2.4 Bio-Artificial Systems Market Competitive Situation and Trends
  2.4.1 Bio-Artificial Systems Market Concentration Rate
  2.4.2 Bio-Artificial Systems Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES BIO-ARTIFICIAL SYSTEMS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Bio-Artificial Systems Sales and Market Share by Type (2011-2016)
3.2 United States Bio-Artificial Systems Revenue and Market Share by Type (2011-2016)
3.3 United States Bio-Artificial Systems Price by Type (2011-2016)
3.4 United States Bio-Artificial Systems Sales Growth Rate by Type (2011-2016)

4 UNITED STATES BIO-ARTIFICIAL SYSTEMS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Bio-Artificial Systems Sales and Market Share by Application (2011-2016)
4.2 United States Bio-Artificial Systems Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES BIO-ARTIFICIAL SYSTEMS MANUFACTURERS PROFILES/ANALYSIS

5.1 Xenios AG (Germany)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Bio-Artificial Systems Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Xenios AG (Germany) Bio-Artificial Systems Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Abbott Diabetes Care, Inc. (USA)
  5.2.2 Bio-Artificial Systems Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Abbott Diabetes Care, Inc. (USA) Bio-Artificial Systems Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Vital Therapies, Inc. (USA)
  5.3.2 Bio-Artificial Systems Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Vital Therapies, Inc. (USA) Bio-Artificial Systems Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Baxter International, Inc. (USA)
  5.4.2 Bio-Artificial Systems Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Baxter International, Inc. (USA) Bio-Artificial Systems Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Asahi Kasei Medical Co., Ltd. (Japan)
  5.5.2 Bio-Artificial Systems Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Asahi Kasei Medical Co., Ltd. (Japan) Bio-Artificial Systems Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Medtronic, Inc. (USA)
  5.6.2 Bio-Artificial Systems Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Medtronic, Inc. (USA) Bio-Artificial Systems Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 HeartWare International, Inc. (USA)
  5.7.2 Bio-Artificial Systems Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 HeartWare International, Inc. (USA) Bio-Artificial Systems Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Fresenius Medical Care AG & Co. KGaA (Germany)
  5.8.2 Bio-Artificial Systems Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Fresenius Medical Care AG & Co. KGaA (Germany) Bio-Artificial Systems Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Thoratec Corp. (USA)
  5.9.2 Bio-Artificial Systems Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Thoratec Corp. (USA) Bio-Artificial Systems Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Toray Medical Co., Ltd. (Japan)
  5.10.2 Bio-Artificial Systems Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Toray Medical Co., Ltd. (Japan) Bio-Artificial Systems Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Nikkiso Co., Ltd. (Japan)
5.12 Nipro Corporation (Japan)
5.13 SynCardia Systems, Inc. (USA)
5.14 Terumo Heart, Inc. (USA)

6 BIO-ARTIFICIAL SYSTEMS MANUFACTURING COST ANALYSIS

6.1 Bio-Artificial Systems Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Bio-Artificial Systems

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Bio-Artificial Systems Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Bio-Artificial Systems Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES BIO-ARTIFICIAL SYSTEMS MARKET FORECAST (2016-2021)

10.1 United States Bio-Artificial Systems Sales, Revenue Forecast (2016-2021)
10.2 United States Bio-Artificial Systems Sales Forecast by Type (2016-2021)
10.3 United States Bio-Artificial Systems Sales Forecast by Application (2016-2021)
10.4 Bio-Artificial Systems Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Bio-Artificial Systems
Table Classification of Bio-Artificial Systems
Figure United States Sales Market Share of Bio-Artificial Systems by Type in 2015
Figure Capillary Hollow Fiber Systems Picture
Figure Direct Perfusion Systems Picture
Figure Entrapment Based Systems Picture
Figure Major BAL Devices Picture
Figure Extracorporeal Liver Assist Device (ELAD) Picture
Figure Hybrid Artificial Liver Support System Picture
Table Application of Bio-Artificial Systems
Figure United States Sales Market Share of Bio-Artificial Systems by Application in 2015
Figure United States Bio-Artificial Systems Sales and Growth Rate (2011-2021)
Figure United States Bio-Artificial Systems Revenue and Growth Rate (2011-2021)
Table United States Bio-Artificial Systems Sales of Key Manufacturers (2015 and 2016)
Table United States Bio-Artificial Systems Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Bio-Artificial Systems Sales Share by Manufacturers
Figure 2016 Bio-Artificial Systems Sales Share by Manufacturers
Table United States Bio-Artificial Systems Revenue by Manufacturers (2015 and 2016)
Table United States Bio-Artificial Systems Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Bio-Artificial Systems Revenue Share by Manufacturers
Table 2016 United States Bio-Artificial Systems Revenue Share by Manufacturers
Table United States Market Bio-Artificial Systems Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Bio-Artificial Systems Average Price of Key Manufacturers in 2015
Figure Bio-Artificial Systems Market Share of Top 3 Manufacturers
Figure Bio-Artificial Systems Market Share of Top 5 Manufacturers
Table United States Bio-Artificial Systems Sales by Type (2011-2016)
Table United States Bio-Artificial Systems Sales Share by Type (2011-2016)
Figure United States Bio-Artificial Systems Sales Market Share by Type in 2015
Table United States Bio-Artificial Systems Revenue and Market Share by Type (2011-2016)
Table United States Bio-Artificial Systems Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Bio-Artificial Systems by Type (2011-2016)
Table United States Bio-Artificial Systems Price by Type (2011-2016)
Figure United States Bio-Artificial Systems Sales Growth Rate by Type (2011-2016)
Table United States Bio-Artificial Systems Sales by Application (2011-2016)
Table United States Bio-Artificial Systems Sales Market Share by Application (2011-2016)
Figure United States Bio-Artificial Systems Sales Market Share by Application in 2015
Table United States Bio-Artificial Systems Sales Growth Rate by Application (2011-2016)
Figure United States Bio-Artificial Systems Sales Growth Rate by Application (2011-2016)
Table Xenios AG (Germany) Basic Information List
Table Xenios AG (Germany) Bio-Artificial Systems Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Xenios AG (Germany) Bio-Artificial Systems Sales Market Share (2011-2016)
Table Abbott Diabetes Care, Inc. (USA) Basic Information List
Table Abbott Diabetes Care, Inc. (USA) Bio-Artificial Systems Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Diabetes Care, Inc. (USA) Bio-Artificial Systems Sales Market Share (2011-2016)
Table Vital Therapies, Inc. (USA) Basic Information List
Table Vital Therapies, Inc. (USA) Bio-Artificial Systems Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vital Therapies, Inc. (USA) Bio-Artificial Systems Sales Market Share (2011-2016)
Table Baxter International, Inc. (USA) Basic Information List
Table Baxter International, Inc. (USA) Bio-Artificial Systems Sales, Revenue, Price and Gross Margin (2011-2016)
Table Baxter International, Inc. (USA) Bio-Artificial Systems Sales Market Share (2011-2016)
Table Asahi Kasei Medical Co., Ltd. (Japan) Basic Information List
Table Asahi Kasei Medical Co., Ltd. (Japan) Bio-Artificial Systems Sales, Revenue, Price and Gross Margin (2011-2016)
Table Asahi Kasei Medical Co., Ltd. (Japan) Bio-Artificial Systems Sales Market Share (2011-2016)
Table Medtronic, Inc. (USA) Basic Information List
Table Medtronic, Inc. (USA) Bio-Artificial Systems Sales, Revenue, Price and Gross Margin (2011-2016)
Table Medtronic, Inc. (USA) Bio-Artificial Systems Sales Market Share (2011-2016)
Table HeartWare International, Inc. (USA) Basic Information List
Table HeartWare International, Inc. (USA) Bio-Artificial Systems Sales, Revenue, Price and Gross Margin (2011-2016)
Table HeartWare International, Inc. (USA) Bio-Artificial Systems Sales Market Share (2011-2016)
Table Fresenius Medical Care AG & Co. KGaA (Germany) Basic Information List
Table Fresenius Medical Care AG & Co. KGaA (Germany) Bio-Artificial Systems Sales, Revenue, Price and Gross Margin (2011-2016)
Table Fresenius Medical Care AG & Co. KGaA (Germany) Bio-Artificial Systems Sales Market Share (2011-2016)
Table Thoratec Corp. (USA) Basic Information List
Table Thoratec Corp. (USA) Bio-Artificial Systems Sales, Revenue, Price and Gross Margin (2011-2016)
Table Thoratec Corp. (USA) Bio-Artificial Systems Sales Market Share (2011-2016)
Table Toray Medical Co., Ltd. (Japan) Basic Information List
Table Toray Medical Co., Ltd. (Japan) Bio-Artificial Systems Sales, Revenue, Price and Gross Margin (2011-2016)
Table Toray Medical Co., Ltd. (Japan) Bio-Artificial Systems Sales Market Share (2011-2016)
Table Nikkiso Co., Ltd. (Japan) Basic Information List
Table Nikkiso Co., Ltd. (Japan) Bio-Artificial Systems Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nikkiso Co., Ltd. (Japan) Bio-Artificial Systems Sales Market Share (2011-2016)
Table Nipro Corporation (Japan) Basic Information List
Table Nipro Corporation (Japan) Bio-Artificial Systems Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nipro Corporation (Japan) Bio-Artificial Systems Sales Market Share (2011-2016)
Table SynCardia Systems, Inc. (USA) Basic Information List
Table SynCardia Systems, Inc. (USA) Bio-Artificial Systems Sales, Revenue, Price and Gross Margin (2011-2016)
Table SynCardia Systems, Inc. (USA) Bio-Artificial Systems Sales Market Share (2011-2016)
Table Terumo Heart, Inc. (USA) Basic Information List
Table Terumo Heart, Inc. (USA) Bio-Artificial Systems Sales, Revenue, Price and Gross Margin (2011-2016)
Table Terumo Heart, Inc. (USA) Bio-Artificial Systems Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bio-Artificial Systems
Figure Manufacturing Process Analysis of Bio-Artificial Systems
Figure Bio-Artificial Systems Industrial Chain Analysis
Table Raw Materials Sources of Bio-Artificial Systems Major Manufacturers in 2015
Table Major Buyers of Bio-Artificial Systems
Table Distributors/Traders List
Figure United States Bio-Artificial Systems Production and Growth Rate Forecast (2016-2021)
Figure United States Bio-Artificial Systems Revenue and Growth Rate Forecast (2016-2021)
Table United States Bio-Artificial Systems Production Forecast by Type (2016-2021)
Table United States Bio-Artificial Systems Consumption Forecast by Application (2016-2021)